Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Opdivo
Opdivo
Star drugs like BMS’ Opdivo, AstraZeneca’s Lynparza will get speedy OKs in China this year, new report predicts
Endpoints
Tue, 01/2/18 - 11:44 am
Bristol-Myers Squibb
AstraZeneca
Opdivo
Lynparza
China
Bristol-Myers teams up with Opdivo maker Ono Pharmaceutical on new I/O programs
Endpoints
Thu, 12/14/17 - 11:16 am
Bristol-Myers Squibb
Opdivo
Ono Pharmaceutical
ONO-4578
immuno-oncology
drug development
Bristol-Myers' Opdivo's Lung Cancer Study Meets Early Success
Yahoo/Zacks.com
Sun, 12/3/17 - 11:21 am
Bristol-Myers Squibb
Opdivo
clinical trials
Docetaxel
China
Bristol-Myers set to get a boost in China as Opdivo aces PhIII lung cancer study early
Endpoints
Fri, 12/1/17 - 09:32 am
Bristol-Myers Squibb
Opdivo
China
Docetaxel
lung cancer
How can new launches mimic Keytruda, Harvoni, and Opdivo? A new report has some ideas
Fierce Pharma
Thu, 11/16/17 - 11:27 am
drug launches
Keytruda
Harvoni
Opdivo
Merck
Bristol-Myers Squibb
Gilead Sciences
The Only 3 Big Pharma Companies Growing Market Share
Motley Fool
Tue, 11/7/17 - 09:59 am
Bristol-Myers Squibb
Opdivo
Shire
Celgene
Bristol-Myers Squibb could double patient numbers for Opdivo in kidney cancer
Fierce Pharma
Wed, 11/1/17 - 11:04 am
Bristol-Myers Squibb
Opdivo
kidney cancer
Why What’s Bad for Merck Is Good For Bristol-Myers
Barron's
Mon, 10/30/17 - 11:07 am
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
Europe
Positive times for Bristol-Myers Squibb
GoinPharma
Sun, 10/22/17 - 09:47 am
Bristol-Myers Squibb
Opdivo
Yervoy
Despite notable failures, cancer vaccines are poised for a leap onto the market: expert
Fierce Pharma
Wed, 10/18/17 - 09:06 am
cancer vaccines
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
The 2 Surprising Reasons Exelixis, Inc. Lost 17% in September
Motley Fool
Thu, 10/5/17 - 06:14 pm
Exelixis
Bristol-Myers Squibb
Opdivo
Bristol-Myers' I-O star Opdivo steps up to challenge Bayer's Stivarga in liver cancer
Fierce Pharma
Mon, 09/25/17 - 11:04 am
Bristol-Myers Squibb
Opdivo
Bayer
Stivarga
liver cancer
AbbVie pairs up another ADC cancer drug with Bristol-Myers Squibb's Opdivo
Fierce Biotech
Sat, 09/23/17 - 10:02 am
AbbVie
Bristol-Myers Squibb
Opdivo
ABBV-399
antibody-drug conjugate
non-small cell lung cancer
2 Important Dates for Big Pharma
Yahoo/GuruFocus
Wed, 09/20/17 - 11:15 pm
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
The Top Cancer Immunotherapies Expected to Reach $1 Billion in Sales in 2017
Motley Fool
Mon, 09/18/17 - 10:53 am
cancer
cancer immunotherapies
Opdivo
Bristol-Myers Squibb
Keytruda
Merck
Yervoy
Which of These 5 Will Be the Best-Selling Drug Worldwide in 2020?
Motley Fool
Sat, 09/16/17 - 12:01 pm
AbbVie
Humira
Celgene
Revlimid
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
Biogen
aducanumab
Exelixis, Inc. and Bristol-Myers Squibb Co. Gear Up for Round 2 of the Kidney Cancer Drug Battle Royale
Motley Fool
Thu, 09/14/17 - 06:56 pm
Exelixis
Bristol-Myers Squibb
kidney cancer
Cabometyx
Opdivo
Yervoy
Bristol To Pay Halozyme $105 Million To Make New Cancer Drugs Easier To Take
Forbes
Thu, 09/14/17 - 09:58 am
Bristol-Myers Squibb
Halozyme
Opdivo
Cancer patients know immuno-oncology and top drugs, but lack details: study
Fierce Pharma
Wed, 09/13/17 - 11:07 am
patients
cancer
immuno-oncology
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
With Yervoy-beating data, Opdivo poised to fight melanoma's return after surgery
Fierce Pharma
Mon, 09/11/17 - 09:52 am
Yervoy
Opdivo
Bristol-Myers Squibb
melanoma
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »